Take cancer from uncertainly to insight
Enabling in-house comprehensive genomic profiling from tissue and liquid biopsy samples with TruSight™ Oncology 500.
Comprehensive Genomic Profiling (CGP) offers a streamlined, faster method for gaining insights into the genomic underpinnings of cancer. With proven solutions and world-class support, the Illumina TruSight Oncology 500 (TSO500) portfolio is ready to enable your CGP efforts.
Download this brochure to learn more about the TSO500 streamlined portfolio. This brochure also covers the following topics:
- Maximizing the value from a limited sample, assessing 500+ genes simultaneously
- An integrated, streamlined workflow using proven NGS technology that enables rapid, reliable CGP
- How to reduce hands-on time by 50% with automation kits
- Innovative library preparation kits offering flexibility in sample input type and throughput
- Accurate, easy-to-use analysis reducing touchpoints and accelerating insights
Fill the form to learn more
By submitting this form, you agree to have your contact information passed along for the purpose of following up on your interests and in order receive communications regarding Oracle products, services, and events. The data sent will be processed in Canada and provided to Oracle who will assume responsibility for processing and Opt-out and Information Removal. For more information, please read our Terms of Use, Privacy, Opt-out & Information Removal below.
© 2022 Msifoworld. All rights reserved.